scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.ANTIVIRAL.2008.10.008 |
P698 | PubMed publication ID | 19028525 |
P2093 | author name string | Bin Li | |
Maria Seifer | |||
Ilaria Serra | |||
April Patty | |||
David N Standring | |||
P433 | issue | 2 | |
P921 | main subject | tenofovir | Q155954 |
P304 | page(s) | 147-155 | |
P577 | publication date | 2008-11-24 | |
P1433 | published in | Antiviral Research | Q4775352 |
P1476 | title | Telbivudine, a nucleoside analog inhibitor of HBV polymerase, has a different in vitro cross-resistance profile than the nucleotide analog inhibitors adefovir and tenofovir | |
P478 | volume | 81 |
Q33711399 | A Review of Antiviral Use for the Treatment of Chronic Hepatitis B Virus Infection in Pregnant Women |
Q34036018 | A cutting-edge view on the current state of antiviral drug development |
Q37768591 | A review of oral antiretroviral therapy for the treatment of chronic hepatitis B. |
Q41705394 | Alisporivir inhibition of hepatocyte cyclophilins reduces HBV replication and hepatitis B surface antigen production |
Q28282376 | Antiviral drug resistance: mechanisms and clinical implications |
Q37255008 | Antiviral resistance and hepatitis B therapy |
Q36467514 | Antiviral therapies: focus on hepatitis B reverse transcriptase |
Q34223779 | Antiviral treatment of chronic hepatitis B virus (HBV) infections |
Q37357573 | Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus |
Q33677072 | Discovery and Development of Anti-HBV Agents and Their Resistance |
Q48053718 | Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China |
Q36765571 | Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-naïve chronic HBV patients. |
Q39213627 | Hepatitis B e antigen-suppressing mutations enhance the replication efficiency of adefovir-resistant hepatitis B virus strains |
Q39649139 | Impact of hepatitis B e antigen-suppressing mutations on the replication efficiency of entecavir-resistant hepatitis B virus strains |
Q38219020 | Molecular diagnosis and treatment of drug-resistant hepatitis B virus |
Q37620354 | Monotherapy versus combination therapy for the treatment of chronic hepatitis B. |
Q28972486 | Safety and efficacy of telbivudine for the treatment of chronic hepatitis B |
Q37775959 | Safety evaluation of telbivudine |
Q37788209 | Telbivudine: a review of its use in compensated chronic hepatitis B. |
Q37779093 | Telbivudine: an effective anti-HBV drug for chronic hepatitis B patients with early on-treatment responses |
Q42159733 | Tenofovir rescue regimen following prior suboptimal response to entecavir and adefovir combination therapy in chronic hepatitis B patients exposed to multiple treatment failures |
Q37247742 | Ultrasensitive genotypic detection of antiviral resistance in hepatitis B virus clinical isolates |
Q33940140 | Unsuccessful therapy with adefovir and entecavir-tenofovir in a patient with chronic hepatitis B infection with previous resistance to lamivudine: a fourteen-year evolution of hepatitis B virus mutations |
Search more.